Tominaga A - Search Results

1

Course and treatment of severe osteoporosis complicated by calciphylaxis: a case report.

Tominaga A, Wada K, Kato Y, Okazaki K. Tominaga A, et al. JBMR Plus. 2024 Nov 22;9(1):ziae154. doi: 10.1093/jbmrpl/ziae154. eCollection 2025 Jan. JBMR Plus. 2024. PMID: 39697523 Free PMC article.

2

Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.

Tominaga A, Wada K, Kato Y, Nishi H, Terayama Y, Okazaki K. Tominaga A, et al. Osteoporos Int. 2021 Apr;32(4):653-661. doi: 10.1007/s00198-020-05639-y. Epub 2020 Sep 26. Osteoporos Int. 2021. PMID: 32979066

3

Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study.

Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kato Y. Tominaga A, et al. Osteoporos Int. 2021 Oct;32(10):1999-2009. doi: 10.1007/s00198-021-05925-3. Epub 2021 Mar 26. Osteoporos Int. 2021. PMID: 33770201 Free PMC article.

4

Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.

Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kodama Y, Kato Y. Tominaga A, et al. Osteoporos Int. 2022 Jun;33(6):1265-1273. doi: 10.1007/s00198-021-06261-2. Epub 2022 Jan 21. Osteoporos Int. 2022. PMID: 35059774

5

Nonresponder Considerations for Romosozumab Treatment.

Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Shimamoto S, Kodama Y, Kato Y. Tominaga A, et al. Calcif Tissue Int. 2023 Aug;113(2):157-165. doi: 10.1007/s00223-023-01087-y. Epub 2023 May 3. Calcif Tissue Int. 2023. PMID: 37138124

6

Responders and non-responders to romosozumab treatment.

Tominaga A, Wada K, Kato Y, Okazaki K. Tominaga A, et al. J Bone Miner Metab. 2024 Dec 7. doi: 10.1007/s00774-024-01570-y. Online ahead of print. J Bone Miner Metab. 2024. PMID: 39645533 Review.

7

O-Arm Assisted Cervicothoracic Spine Pedicle Screw Placement Accuracy Is Higher Than C-Arm Fluoroscopy.

Inoue T, Wada K, Tominaga A, Tamaki R, Hirota T, Okazaki K. Inoue T, et al. Among authors: tominaga a. World Neurosurg. 2022 Feb;158:e996-e1001. doi: 10.1016/j.wneu.2021.12.006. Epub 2021 Dec 7. World Neurosurg. 2022. PMID: 34890848

8

Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?.".

Tominaga A, Wada K, Okazaki K, Nishi H, Terayama Y, Kato Y. Tominaga A, et al. Osteoporos Int. 2022 Jun;33(6):1401-1402. doi: 10.1007/s00198-022-06300-6. Epub 2022 Feb 18. Osteoporos Int. 2022. PMID: 35181822 No abstract available.

9

Joint-Preserving Surgery for Forefoot Deformities in Patients with Rheumatoid Arthritis: A Literature Review.

Yano K, Ikari K, Tobimatsu H, Tominaga A, Okazaki K. Yano K, et al. Among authors: tominaga a. Int J Environ Res Public Health. 2021 Apr 13;18(8):4093. doi: 10.3390/ijerph18084093. Int J Environ Res Public Health. 2021. PMID: 33924481 Free PMC article. Review.

10

Outcomes of Joint-Preserving Surgery for Forefoot Deformities in Patients With Rheumatoid Arthritis.

Tominaga A, Ikari K, Yamada A, Yano K, Okazaki K. Tominaga A, et al. Foot Ankle Int. 2024 Mar;45(3):261-271. doi: 10.1177/10711007241226898. Epub 2024 Feb 8. Foot Ankle Int. 2024. PMID: 38327241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters